ResearcherShanxi Medical UniversityNo recent work listed
Xueliang Qin
Matched on OpenAlex author ID A5087181159.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 5
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 3
- The integrated landscape of fatty acid metabolism subtypes reveals with prognostic and therapeutic relevance in pancreatic cancer. Co-author DOI 10.3389/fgstr.2022.969533↗
- Methyl-indole inhibits pancreatic cancer cell viability by down-regulating ZFX expression. First author DOI 10.1007/s13205-020-02179-4↗
- Genetic polymorphisms and pancreatic cancer risk: A PRISMA-compliant systematic review and meta-analysis. Co-author DOI 10.1097/md.0000000000016541↗
Closest collaborators
The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Xiaopeng Cui · 1 shared paper, 2020
- Daguang Fan · 1 shared paper, 2022
- Peng Dai · 1 shared paper, 2022
- Yanzhong Zhang · 1 shared paper, 2019
- Peng Dai · 1 shared paper, 2019
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.